General recommendation for assessment and management on the risk of glucocorticoid-induced osteonecrosis in patients with COVID-19
Research article
[키워드] acute respiratory syndrome
average
blood flow
calculated
caused
China
Clinical characteristics
Clinical data
conducted
convalescent COVID-19 patients
Coronavirus disease 2019
COVID-19
COVID-19 patient
COVID-19 patients
cross-sectional
cumulative
Diagnosis
disease
Disease prevention and control
dosage
dose
Evidence
favor
Follow-up
glucocorticoid
Glucocorticoid treatment
Glucocorticoids
High dose
incidence
induce
Infection
joint destruction
joints
management
Meta-analysis
Methylprednisolone
observation
occurred
Occurrence
osteonecrosis
pathogen
Pathogenesis
Patient
patients with COVID-19
performed
Prognosis
protocol
receiving
reduced
Research
Result
risk
SARS patient
Severe acute respiratory syndrome
similarity
supported
systematic review
Therapeutic strategies
therapy
therapy for COVID-19
translational
Treatment
Wuhan
[DOI] 10.1016/j.jot.2021.09.005 [Article Type] Research article
[DOI] 10.1016/j.jot.2021.09.005 [Article Type] Research article